Predictive factors of psychiatric syndrome in patients with systemic lupus erythematosus

Early detection of neuropsychiatric systemic lupus erythematosus (NPSLE) remains a challenge in clinical settings. Previous studies have found different autoantibodies as markers for NPSLE. This study aimed to describe the distribution of psychiatric syndromes in a group of patients with systemic lu...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 15; p. 1323209
Main Authors Geng, Wenqi, Zhang, Shangzhu, Cao, Jinya, Hong, Xia, Duan, Yanping, Jiang, Yinan, Wei, Jing
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Early detection of neuropsychiatric systemic lupus erythematosus (NPSLE) remains a challenge in clinical settings. Previous studies have found different autoantibodies as markers for NPSLE. This study aimed to describe the distribution of psychiatric syndromes in a group of patients with systemic lupus erythematosus (SLE) and to investigate the association between psychiatric syndromes and specific autoantibodies. This retrospective study was conducted at a single medical center in China. We reviewed medical records of hospitalized patients with SLE who were consulted by psychiatrists due to potential mental disorders. Results of serum autoantibodies and general laboratory tests were collected. The correlation between clinical variables was examined. Binary logistic regression analyses were used to determine factors related to NPSLE and different psychiatric diagnoses. Among the 171 psychiatric manifestations in 160 patients, 141 (82.4%) were attributed to SLE. Acute confusional state (ACS) had the highest prevalence (57.4%). Anti-cardiolipin (ACL) antibody ( 142.261, p < 0.001) and anti-β2 glycoprotein I (-β2GP1) antibody ( 139.818, p < 0.001) varied significantly between groups, with the highest positive rate found in patients with mood disorders (27.3% and 18.2%). SLE disease activity index - 2000 (SLEDAI-2K) score excluding item ACS and item psychosis was a predictor of NPSLE (OR 1.172 [95% CI 1.105 - 1.243]). Disease activity reflected by SLEDAI-2K score is a predictor for NPSLE. Antiphospholipid antibodies are associated with mood disorders in SLE. Further separate investigation of neuropsychiatric disorders is needed in order to better comprehend NPSLE's pathological mechanism.
AbstractList IntroductionEarly detection of neuropsychiatric systemic lupus erythematosus (NPSLE) remains a challenge in clinical settings. Previous studies have found different autoantibodies as markers for NPSLE. This study aimed to describe the distribution of psychiatric syndromes in a group of patients with systemic lupus erythematosus (SLE) and to investigate the association between psychiatric syndromes and specific autoantibodies.MethodsThis retrospective study was conducted at a single medical center in China. We reviewed medical records of hospitalized patients with SLE who were consulted by psychiatrists due to potential mental disorders. Results of serum autoantibodies and general laboratory tests were collected. The correlation between clinical variables was examined. Binary logistic regression analyses were used to determine factors related to NPSLE and different psychiatric diagnoses.ResultsAmong the 171 psychiatric manifestations in 160 patients, 141 (82.4%) were attributed to SLE. Acute confusional state (ACS) had the highest prevalence (57.4%). Anti-cardiolipin (ACL) antibody (X2 = 142.261, p < 0.001) and anti-β2 glycoprotein I (-β2GP1) antibody (X2 = 139.818, p < 0.001) varied significantly between groups, with the highest positive rate found in patients with mood disorders (27.3% and 18.2%). SLE disease activity index – 2000 (SLEDAI-2K) score excluding item ACS and item psychosis was a predictor of NPSLE (OR 1.172 [95% CI 1.105 - 1.243]).ConclusionsDisease activity reflected by SLEDAI-2K score is a predictor for NPSLE. Antiphospholipid antibodies are associated with mood disorders in SLE. Further separate investigation of neuropsychiatric disorders is needed in order to better comprehend NPSLE’s pathological mechanism.
Early detection of neuropsychiatric systemic lupus erythematosus (NPSLE) remains a challenge in clinical settings. Previous studies have found different autoantibodies as markers for NPSLE. This study aimed to describe the distribution of psychiatric syndromes in a group of patients with systemic lupus erythematosus (SLE) and to investigate the association between psychiatric syndromes and specific autoantibodies. This retrospective study was conducted at a single medical center in China. We reviewed medical records of hospitalized patients with SLE who were consulted by psychiatrists due to potential mental disorders. Results of serum autoantibodies and general laboratory tests were collected. The correlation between clinical variables was examined. Binary logistic regression analyses were used to determine factors related to NPSLE and different psychiatric diagnoses. Among the 171 psychiatric manifestations in 160 patients, 141 (82.4%) were attributed to SLE. Acute confusional state (ACS) had the highest prevalence (57.4%). Anti-cardiolipin (ACL) antibody ( 142.261, p < 0.001) and anti-β2 glycoprotein I (-β2GP1) antibody ( 139.818, p < 0.001) varied significantly between groups, with the highest positive rate found in patients with mood disorders (27.3% and 18.2%). SLE disease activity index - 2000 (SLEDAI-2K) score excluding item ACS and item psychosis was a predictor of NPSLE (OR 1.172 [95% CI 1.105 - 1.243]). Disease activity reflected by SLEDAI-2K score is a predictor for NPSLE. Antiphospholipid antibodies are associated with mood disorders in SLE. Further separate investigation of neuropsychiatric disorders is needed in order to better comprehend NPSLE's pathological mechanism.
Early detection of neuropsychiatric systemic lupus erythematosus (NPSLE) remains a challenge in clinical settings. Previous studies have found different autoantibodies as markers for NPSLE. This study aimed to describe the distribution of psychiatric syndromes in a group of patients with systemic lupus erythematosus (SLE) and to investigate the association between psychiatric syndromes and specific autoantibodies.IntroductionEarly detection of neuropsychiatric systemic lupus erythematosus (NPSLE) remains a challenge in clinical settings. Previous studies have found different autoantibodies as markers for NPSLE. This study aimed to describe the distribution of psychiatric syndromes in a group of patients with systemic lupus erythematosus (SLE) and to investigate the association between psychiatric syndromes and specific autoantibodies.This retrospective study was conducted at a single medical center in China. We reviewed medical records of hospitalized patients with SLE who were consulted by psychiatrists due to potential mental disorders. Results of serum autoantibodies and general laboratory tests were collected. The correlation between clinical variables was examined. Binary logistic regression analyses were used to determine factors related to NPSLE and different psychiatric diagnoses.MethodsThis retrospective study was conducted at a single medical center in China. We reviewed medical records of hospitalized patients with SLE who were consulted by psychiatrists due to potential mental disorders. Results of serum autoantibodies and general laboratory tests were collected. The correlation between clinical variables was examined. Binary logistic regression analyses were used to determine factors related to NPSLE and different psychiatric diagnoses.Among the 171 psychiatric manifestations in 160 patients, 141 (82.4%) were attributed to SLE. Acute confusional state (ACS) had the highest prevalence (57.4%). Anti-cardiolipin (ACL) antibody (X2 = 142.261, p < 0.001) and anti-β2 glycoprotein I (-β2GP1) antibody (X2 = 139.818, p < 0.001) varied significantly between groups, with the highest positive rate found in patients with mood disorders (27.3% and 18.2%). SLE disease activity index - 2000 (SLEDAI-2K) score excluding item ACS and item psychosis was a predictor of NPSLE (OR 1.172 [95% CI 1.105 - 1.243]).ResultsAmong the 171 psychiatric manifestations in 160 patients, 141 (82.4%) were attributed to SLE. Acute confusional state (ACS) had the highest prevalence (57.4%). Anti-cardiolipin (ACL) antibody (X2 = 142.261, p < 0.001) and anti-β2 glycoprotein I (-β2GP1) antibody (X2 = 139.818, p < 0.001) varied significantly between groups, with the highest positive rate found in patients with mood disorders (27.3% and 18.2%). SLE disease activity index - 2000 (SLEDAI-2K) score excluding item ACS and item psychosis was a predictor of NPSLE (OR 1.172 [95% CI 1.105 - 1.243]).Disease activity reflected by SLEDAI-2K score is a predictor for NPSLE. Antiphospholipid antibodies are associated with mood disorders in SLE. Further separate investigation of neuropsychiatric disorders is needed in order to better comprehend NPSLE's pathological mechanism.ConclusionsDisease activity reflected by SLEDAI-2K score is a predictor for NPSLE. Antiphospholipid antibodies are associated with mood disorders in SLE. Further separate investigation of neuropsychiatric disorders is needed in order to better comprehend NPSLE's pathological mechanism.
Author Hong, Xia
Geng, Wenqi
Zhang, Shangzhu
Wei, Jing
Duan, Yanping
Cao, Jinya
Jiang, Yinan
Author_xml – sequence: 1
  givenname: Wenqi
  surname: Geng
  fullname: Geng, Wenqi
– sequence: 2
  givenname: Shangzhu
  surname: Zhang
  fullname: Zhang, Shangzhu
– sequence: 3
  givenname: Jinya
  surname: Cao
  fullname: Cao, Jinya
– sequence: 4
  givenname: Xia
  surname: Hong
  fullname: Hong, Xia
– sequence: 5
  givenname: Yanping
  surname: Duan
  fullname: Duan, Yanping
– sequence: 6
  givenname: Yinan
  surname: Jiang
  fullname: Jiang, Yinan
– sequence: 7
  givenname: Jing
  surname: Wei
  fullname: Wei, Jing
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38585267$$D View this record in MEDLINE/PubMed
BookMark eNp9kcFrHCEUxqWkNGmaf6CHMMdcdjv6HHWPJSRtINAeWuhNHH12DTPjRJ2E_e9rsptScqggyvP3fT7e954cTXFCQj7Sdg2gNp98GMdlzVrG1xQYsHbzhpxQIfgKGONH_9yPyVnOd21dfAMA3TtyDKpTHRPyhPz6ntAFW8IDNt7YElNuom_mvLPbYEoKtsm7yaU4YhOmZjYl4FRy8xjKtr7kgmNFhmVecoNpV7Y4mhLzkj-Qt94MGc8O5yn5eX314_Lr6vbbl5vLz7cryymUlek4St4b3vVSgQXHrRKd6LmUjksrO6ekcI7auqGl3gC6Td8qVXHvvIRTcrP3ddHc6TmF0aSdjibo50JMv7VJJdgBtRdgOmFRMu45FUwprxRDSdFIaZBXr4u915zi_YK56DFki8NgJoxL1tBC7QukgIqeH9ClH9H9_fhlshVQe8CmmHNCr20odXpxKsmEQdNWP-Won3PUTznqQ45Vyl5JX9z_I_oDt5Gi3g
CitedBy_id crossref_primary_10_1007_s10067_024_07056_6
crossref_primary_10_5498_wjp_v15_i2_102247
crossref_primary_10_1111_1756_185X_70178
crossref_primary_10_3390_biom14080905
Cites_doi 10.1136/lupus-2022-000668
10.1002/acr.21691
10.1038/mp.2013.20
10.1038/s41584-018-0156-8
10.1038/nrrheum.2010.62
10.1136/lupus-2023-001005
10.1016/j.autrev.2021.102780
10.1016/j.jaut.2016.06.013
10.1002/art.40930
10.1111/j.1399-5618.2012.01024.x
10.1503/cmaj.080697
10.5606/ArchRheumatol.2019.6981
10.1016/j.autrev.2015.10.003
10.1038/nrrheum.2014.15
10.1212/wnl.57.3.496
10.1002/art.34473
10.3389/fmed.2018.00138
10.1016/j.jad.2018.08.040
10.1128/CVI.13.1.77-83.2006
10.1007/s10067-021-06034-6
10.1136/annrheumdis-2013-204838
10.1055/s-0042-1756193
10.3389/fimmu.2023.1157149
10.1002/(ISSN)1529-0131
10.1007/s40265-015-0534-3
10.1136/ard.2010.130476
10.1136/bmjopen-2016-015546
10.1038/nrneurol.2014.148
10.1177/09612033231151600
10.1136/annrheumdis-2019-216150
10.1016/j.semarthrit.2012.03.011
ContentType Journal Article
Copyright Copyright © 2024 Geng, Zhang, Cao, Hong, Duan, Jiang and Wei.
Copyright_xml – notice: Copyright © 2024 Geng, Zhang, Cao, Hong, Duan, Jiang and Wei.
DBID AAYXX
CITATION
NPM
7X8
DOA
DOI 10.3389/fimmu.2024.1323209
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
ExternalDocumentID oai_doaj_org_article_f63a56ce724f416288f882e71ea77ae4
38585267
10_3389_fimmu_2024_1323209
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
IPNFZ
NPM
RIG
7X8
ID FETCH-LOGICAL-c413t-a54e74ba45b783c3d4c8656b477d47c75d876dd1cdd1301fa3ed9b088b78fdf73
IEDL.DBID M48
ISSN 1664-3224
IngestDate Wed Aug 27 01:30:50 EDT 2025
Fri Jul 11 16:15:56 EDT 2025
Mon Jul 21 05:47:20 EDT 2025
Tue Jul 01 01:40:31 EDT 2025
Thu Apr 24 22:58:32 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords neuropsychiatric systemic lupus erythematosus
systemic lupus erythematosus
referral consultation
biomarkers
mental disorders
Language English
License Copyright © 2024 Geng, Zhang, Cao, Hong, Duan, Jiang and Wei.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c413t-a54e74ba45b783c3d4c8656b477d47c75d876dd1cdd1301fa3ed9b088b78fdf73
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2024.1323209
PMID 38585267
PQID 3034773763
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_f63a56ce724f416288f882e71ea77ae4
proquest_miscellaneous_3034773763
pubmed_primary_38585267
crossref_citationtrail_10_3389_fimmu_2024_1323209
crossref_primary_10_3389_fimmu_2024_1323209
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-00-00
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – year: 2024
  text: 2024-00-00
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2024
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Ho (B12) 2016; 15
Yuan (B23) 2018; 34
Chessa (B26) 2023; 10
(B6) 1999; 42
Borowoy (B15) 2012; 42
Bertsias (B19) 2010; 69
Hanly (B1) 2020; 79
Hirohata (B14) 2018; 36
Cervera (B28) 2015; 74
Carrión-Barberà (B5) 2021; 20
Cocco (B16) 2023; 14
Bortoluzzi (B8) 2017; 7
Taylor (B33) 2013; 18
Gris (B30) 2023; 49
Hanly (B3) 2014; 10
Bertsias (B4) 2010; 6
Ding (B25) 2022; 41
Hélène Jeltsch-David (B21) 2014; 10
Aringer (B9) 2019; 71
Toma (B34) 2018; 241
Petri (B17) 2012; 64
aan het Rot (B32) 2009; 180
Mahler (B24) 2006
Hanly (B27) 2022; 9
Murray (B29) 2012; 64
Schwartz (B10) 2019; 15
Magro-Checa (B11) 2016; 76
Govoni (B2) 2016; 74
Ainiala (B7) 2001; 57
Vivaldo (B22) 2018; 5
Hasegawa (B13) 2023; 32
Schneider (B31) 2012; 14
Gladman (B20) 2002; 29
(B18) 1993
References_xml – volume: 9
  year: 2022
  ident: B27
  article-title: Role of autoantibodies and blood-brain barrier leakage in cognitive impairment in systemic lupus erythematosus
  publication-title: Lupus Sci Med
  doi: 10.1136/lupus-2022-000668
– volume: 64
  year: 2012
  ident: B29
  article-title: Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.21691
– volume-title: The ICD-10 classification of mental and behavioural disorders
  year: 1993
  ident: B18
– volume: 18
  year: 2013
  ident: B33
  article-title: The vascular depression hypothesis: mechanisms linking vascular disease with depression
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2013.20
– volume: 15
  year: 2019
  ident: B10
  article-title: Neuropsychiatric lupus: new mechanistic insights and future treatment directions
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/s41584-018-0156-8
– volume: 36
  year: 2018
  ident: B14
  article-title: Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus
  publication-title: Clin Exp Rheumatol
– volume: 6
  year: 2010
  ident: B4
  article-title: Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2010.62
– volume: 10
  year: 2023
  ident: B26
  article-title: The effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study
  publication-title: Lupus Sci Med
  doi: 10.1136/lupus-2023-001005
– volume: 20
  year: 2021
  ident: B5
  article-title: Neuropsychiatric involvement in systemic lupus erythematosus: A review
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2021.102780
– volume: 74
  start-page: 41
  year: 2016
  ident: B2
  article-title: The diagnosis and clinical management of the neuropsychiatric manifestations of lupus
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2016.06.013
– volume: 71
  year: 2019
  ident: B9
  article-title: 2019 european league against rheumatism/american college of rheumatology classification criteria for systemic lupus erythematosus
  publication-title: Arthritis Rheumatol (Hoboken N.J.)
  doi: 10.1002/art.40930
– volume: 14
  year: 2012
  ident: B31
  article-title: Neuroprogression in bipolar disorder
  publication-title: Bipolar Disord
  doi: 10.1111/j.1399-5618.2012.01024.x
– volume: 180
  year: 2009
  ident: B32
  article-title: Neurobiological mechanisms in major depressive disorder
  publication-title: CMAJ
  doi: 10.1503/cmaj.080697
– volume: 34
  year: 2018
  ident: B23
  article-title: The predictive value of autoantibody spectrum on organ damage in patients with systemic lupus erythematosus
  publication-title: Arch Rheumatol
  doi: 10.5606/ArchRheumatol.2019.6981
– volume: 15
  year: 2016
  ident: B12
  article-title: A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2015.10.003
– volume: 10
  year: 2014
  ident: B3
  article-title: Diagnosis and management of neuropsychiatric SLE
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2014.15
– volume: 57
  start-page: 496
  year: 2001
  ident: B7
  article-title: The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus
  publication-title: Neurology
  doi: 10.1212/wnl.57.3.496
– volume: 64
  year: 2012
  ident: B17
  article-title: Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.34473
– volume: 5
  year: 2018
  ident: B22
  article-title: Definition of NPSLE: does the ACR nomenclature still hold
  publication-title: Front Med (Lausanne)
  doi: 10.3389/fmed.2018.00138
– volume: 241
  year: 2018
  ident: B34
  article-title: Cerebral blood flow in bipolar disorder: A systematic review
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2018.08.040
– start-page: 77
  year: 2006
  ident: B24
  article-title: International multicenter evaluation of autoantibodies to ribosomal P proteins
  publication-title: Clin Vaccine Immunol CVI
  doi: 10.1128/CVI.13.1.77-83.2006
– volume: 29
  year: 2002
  ident: B20
  article-title: Systemic lupus erythematosus disease activity index 2000
  publication-title: J Rheumatol
– volume: 41
  year: 2022
  ident: B25
  article-title: The role of anti-ribosomal P autoantibodies in the prediction of neuropsychiatric damage in systemic lupus erythematosus based on CSTAR cohort (XIV)
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-021-06034-6
– volume: 74
  year: 2015
  ident: B28
  article-title: Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-204838
– volume: 49
  year: 2023
  ident: B30
  article-title: Antiphospholipid antibodies in pregnancy: maternal and neonatal implications
  publication-title: Semin Thromb Hemost
  doi: 10.1055/s-0042-1756193
– volume: 14
  year: 2023
  ident: B16
  article-title: Brainreactive autoantibodies in neuropsychiatric systemic lupus erythematosus
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2023.1157149
– volume: 42
  start-page: 599
  year: 1999
  ident: B6
  article-title: The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes
  publication-title: Arthritis Rheum
  doi: 10.1002/(ISSN)1529-0131
– volume: 76
  year: 2016
  ident: B11
  article-title: Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives
  publication-title: Drugs
  doi: 10.1007/s40265-015-0534-3
– volume: 69
  year: 2010
  ident: B19
  article-title: EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2010.130476
– volume: 7
  year: 2017
  ident: B8
  article-title: Validity of the Italian algorithm for the attribution of neuropsychiatric events in systemic lupus erythematosus: a retrospective multicentre international diagnostic cohort study
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2016-015546
– volume: 10
  start-page: 579
  year: 2014
  ident: B21
  article-title: Neuropsychiatric systemic lupus erythematosus pathogenesis and biomarkers
  publication-title: Nat Rev Neurol
  doi: 10.1038/nrneurol.2014.148
– volume: 32
  year: 2023
  ident: B13
  article-title: The pathogenic role of lupus-specific autoantibodies and Interleukin-6 on demyelination of the brainstem and spinal cord in systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1177/09612033231151600
– volume: 79
  year: 2020
  ident: B1
  article-title: Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2019-216150
– volume: 42
  year: 2012
  ident: B15
  article-title: Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort
  publication-title: Semin Arthritis rheumatism
  doi: 10.1016/j.semarthrit.2012.03.011
SSID ssj0000493335
Score 2.3935375
SecondaryResourceType review_article
Snippet Early detection of neuropsychiatric systemic lupus erythematosus (NPSLE) remains a challenge in clinical settings. Previous studies have found different...
IntroductionEarly detection of neuropsychiatric systemic lupus erythematosus (NPSLE) remains a challenge in clinical settings. Previous studies have found...
SourceID doaj
proquest
pubmed
crossref
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
StartPage 1323209
SubjectTerms biomarkers
mental disorders
neuropsychiatric systemic lupus erythematosus
referral consultation
systemic lupus erythematosus
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8NAEF6kIHgR39YXK3iTWLOPbHNUsRRB8WCht2WfUGnT0jSH_ntns2mpB_XiIZcwIZvZ2ZlvdjbfIHSjnOLa2zRJuXMJyw1Lcu3vE5VZmjOiKan3IV_fsv6AvQz5cKPVVzgTFumBo-I6PqOKZ8YJwjyAB9LtegCFTqROCaFczQQKMW8jmfqMuJdSyuNfMpCF5R0_mkwqyAcJu4MEDIaQf4tENWH_zyizjja9PbTbwET8EIe3j7ZccYC2Y-PI5SEavs9DgSW4Ktx0zMFTj9dHl0cGr6gI8KjADXlqicOuK47kzSAyrmZVid18GZlbp2VVHqFB7_njqZ80PRISA-FnkSjOnGBaMa5FlxpqmekCRNNMCMuEEdyCu7M2NXDBWvaKOptrcC0g7q0X9Bi1imnhThE2KReEwvrPbcaE1VoRYz1hxllKUkPaKF3pS5qGQDz0sRhLSCSCjmWtYxl0LBsdt9Ht-plZpM_4VfoxTMNaMlBf1zfAIGRjEPIvg2ij69UkSlgqof6hCjetSgnRGtQSPGobncTZXb-qro-STJz9xxDO0U74rLhTc4Fai3nlLgG7LPRVbaZf1vHtJg
  priority: 102
  providerName: Directory of Open Access Journals
Title Predictive factors of psychiatric syndrome in patients with systemic lupus erythematosus
URI https://www.ncbi.nlm.nih.gov/pubmed/38585267
https://www.proquest.com/docview/3034773763
https://doaj.org/article/f63a56ce724f416288f882e71ea77ae4
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Li9RAEG7WFcGL-HZWXVrwJlnt7kp6chBRcV2EFQ8OzK3pp4zMJmsygZ1_b_VjBgRX8JBAQuVBVderO_k-Ql5qr2sTHKtY7X0FrYWqNeFNpRsnWuBG8DQPef61OVvAl2W9PCA7uqOiwPGvrV3kk1oM65OrX9t36PBvY8eJ-fZ1WF1cTNjqcTjB3grv3t4gNzEzychocF7K_Z-5GhYicW6ypoEKxzLk_2iuuc0fuSpB-l9fh6Z8dHqX3CmFJH2fLX-PHPjuPrmVqSW3D8jy2xCXYGIwo4VTh_aB7j9uXlm6Ayugq44WeNWRxnlZmuGdUWQ9XU4j9cM2Y7v24zQ-JIvTT98_nlWFRaGymKA2la7BSzAaaiPnwgoHdo5FnAEpHUgra4cB0TlmcUNvD1p41xoMPigeXJDiETns-s4_IdSyWnKBEaJ1DUhnjObWBQ7WO8GZ5TPCdvpStkCMR6aLtcJWI-pYJR2rqGNVdDwjr_bXXGaAjX9Kf4hm2EtGcOx0oh9-qOJrKjRC1431kkPAepPP5wH7CC-Z11JqDzPyYmdEhc4UV0h05_tpVJjPUS0x5s7I42zd_aPSCipv5NF_vfBTcjse5kmbZ-RwM0z-OZYxG3Oc2n_cf16y4zROfwOUGvES
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictive+factors+of+psychiatric+syndrome+in+patients+with+systemic+lupus+erythematosus&rft.jtitle=Frontiers+in+immunology&rft.au=Geng%2C+Wenqi&rft.au=Zhang%2C+Shangzhu&rft.au=Cao%2C+Jinya&rft.au=Hong%2C+Xia&rft.date=2024&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=15&rft_id=info:doi/10.3389%2Ffimmu.2024.1323209&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fimmu_2024_1323209
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon